Most Common Adverse Events Key Observations: Gastrointestinal adverse events are dose-dependent and most pronounced during dose escalation Symptoms typically peak within the first 4-8 weeks and diminish with continued treatment as tolerance develops Slow titration (4-week intervals) significantly reduces the incidence and severity of GI events Most adverse events classified as mild to moderate in severity [9] Discontinuation Rates 7.3% Placebo discontinuation rate [9] 15.8% Cagrilintide 2.4 mg (optimal dose) [9] 24.5% Cagrilintide 4.5 mg (high dose) [9] The majority of discontinuations due to adverse events occurred during the titration phase, with GI symptoms (nausea, vomiting) being the primary reasons
"One in eight people globally have a mental health disorder, which means everyone on our team likely knows someone affected by mental health challenges," said Wes Hartig, CEO at MedOne
Because these injections are not regulated by the FDA in the same way as medications, there can be variations in quality and composition
Additionally, a detailed medication history in relation to the diagnosis is required, underscoring the plan's commitment to informed and responsible medication management
10.1016/j.nbd.2011.04.025 Neurobiol
But pharmaceutical firms are already making adjustments overseas: Eli Lilly recently raised its UK GLP-1 prices by 170% to offset possible MFN-related revenue losses and maintain current pricing levels in the U.S
